Literature DB >> 6449178

Skin pigmentation secondary to minocycline therapy.

J D McGrae, A S Zelickson.   

Abstract

Localized brown to blue-black discoloration of the skin occurred in three patients receiving long-term minocycline hydrochloride therapy. Abundant perivascular pigmented material was present at all levels of the dermis below the upper papillary portion. Histochemical studies demonstrated reactivity with the Prussian blue stain and the Fontana-Masson silver technique. The granules were brightly refractile by dark-field illumination. Ultrastructurally, there were membrane-bound dense intracellular inclusions differing from melanin and iron but identical to those known to occur in the thyroid glands of minocycline-primed laboratory animals. The abnormal pigment most likely represents a metabolic derivative of minocycline.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6449178

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  6 in total

1.  [Skin blackish hyperpigmentation in 3 patients].

Authors:  O Bock; U Mrowietz; R Gläser
Journal:  Hautarzt       Date:  2002-06       Impact factor: 0.751

2.  New developments in acne treatment.

Authors:  L P Stolman
Journal:  Can Fam Physician       Date:  1982-08       Impact factor: 3.275

3.  A 54-year-old woman with bluish discoloration of her sclera.

Authors:  Isabella Phan; Rachel Kaiser; Cynthia Chiu
Journal:  Digit J Ophthalmol       Date:  2010-05-08

Review 4.  Drug eruptions.

Authors:  S K Goolamali
Journal:  Postgrad Med J       Date:  1985-10       Impact factor: 2.401

5.  Thyroid gland pigmentation and minocycline therapy.

Authors:  G Gordon; B M Sparano; A W Kramer; R G Kelly; M J Iatropoulos
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

6.  Minocycline-Induced Cutaneous Hyperpigmentation in an Orthopedic Patient Population.

Authors:  Yuri Hanada; Elie F Berbari; James M Steckelberg
Journal:  Open Forum Infect Dis       Date:  2016-01-29       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.